You are here

Genentech

Drug combo helps women with early breast cancer

Yahoo/AP

Sat, 12/11/10 - 12:00 pm

Genentech: positive results from cancer drug study

Yahoo/AP

Mon, 12/6/10 - 11:00 am

non-Hodgkin's lymphoma

No Room for RNAi in Roche's Operational Excellence Plans

InVivo

Wed, 11/17/10 - 01:02 pm

The Axe Finally Falls: Roche To Cut 4,800 Jobs

Pharmalot

Wed, 11/17/10 - 11:45 am

Small study affirms Avastin as AMD treatment

Fierce Pharma

Mon, 10/4/10 - 10:15 am

age-related macular degeneration

Roche's Avastin Fails to Help Early-Stage Colon Cancer Patients in Study

Bloomberg

Mon, 09/20/10 - 11:33 am

F.D.A. Postpones Rule on Breast Cancer Drug

NY Times

Sat, 09/18/10 - 11:27 am

BCA’s Brenner: Avastin And FDA Approval Standards

Pharmalot

Tue, 09/14/10 - 10:14 am

Roche Layoffs: Whose Jobs Are Safe, and Whose Aren’t?

BNET Pharma

Tue, 09/7/10 - 12:12 pm

Genentech Receives Refuse to File Letter from FDA for T-DM1

Yahoo

Fri, 08/27/10 - 06:32 am

Trastuzumab-Dm1

Curis shares sink as Genentech evaluates lead drug's fate

Fierce Biotech

Mon, 08/9/10 - 10:13 am

Big Biotech: End of an Era

Seeking Alpha

Wed, 07/28/10 - 10:17 am

Gilead Sciences

Human Genome Sciences

Vertex Pharmaceuticals

Roche Profit Up on Genentech Synergies

NY Times, NY

Thu, 07/22/10 - 08:53 am

Genentech's New Option for Breast Cancer Patients

Seeking Alpha

Sun, 07/11/10 - 02:31 pm

Trastuzumab-Dm1

Genentech says Lucentis gets new FDA approval

Yahoo/AP

Wed, 06/23/10 - 09:14 am

A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year

WSJ

Thu, 06/17/10 - 09:46 am

macular degeneration

Regeneron’s $2 Billion Research Push Mimics Genentech

Bloomberg

Wed, 06/9/10 - 08:11 am

Rituxan, Revlimid win in maintenance trials

Fierce Pharma

Fri, 05/21/10 - 11:26 am

clinical trials

US warns Roche, Shire on misleading drug promotions

Reuters

Thu, 05/6/10 - 08:55 am

New licensing chiefs for AZ, Genentech talk deal strategy

Fierce Biotech

Thu, 05/6/10 - 08:52 am

Pages